Alleviation of renal ischemia/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Renal ischemia followed by reperfusion (I/R) is a leading cause of acute kidney injury (AKI), which is closely associated with high morbidity and mortality. Studies have shown that induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (iMSCs) exert powerful therapeutic effects in renal ischemia. However, the efficacy of iMSC-derived exosomes (iExo) on I/R injuries remains largely unknown. Methods: Human iPSCs were differentiated into iMSCs using a modified one-step method. Ultrafiltration, combined with purification, was used to isolate iExo from iMSCs. iExo was administered following I/R injury in a mouse model. The effect of iExo on I/R injury was assessed through changes in renal function, histology, and expression of oxidative stress, inflammation, and apoptosis markers. Further, we evaluated its association with the extracellular signal-regulated kinase (ERK) 1/2 signaling pathway. Results: Mice subjected to I/R injury exhibited typical AKI patterns; serum creatinine level, tubular necrosis, apoptosis, inflammatory cytokine production, and oxidative stress were markedly increased compared to sham mice. However, treatment with iExo attenuated these changes, significantly improving renal function and tissue damage, similar to the renoprotective effects of iMSCs on I/R injury. Significant induction of activated ERK 1/2 signaling molecules was observed in mice treated with iExo compared to those in the I/R injury group. Conclusions: The present study demonstrates that iExo administration ameliorated renal damage following I/R, suggesting that iMSC-derived exosomes may provide a novel therapeutic approach for AKI treatment.
Abstract
Background/Aims: Renal ischemia followed by reperfusion (I/R) is a leading cause of acute kidney injury (AKI), which is closely associated with high morbidity and mortality. Studies have shown that induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (iMSCs) exert powerful therapeutic effects in renal ischemia. However, the efficacy of iMSC-derived exosomes (iExo) on I/R injuries remains largely unknown. Methods: Human iPSCs were differentiated into iMSCs using a modified one-step method. Ultrafiltration, combined with purification, was used to isolate iExo from iMSCs. iExo was administered following I/R injury in a mouse model. The effect of iExo on I/R injury was assessed through changes in renal function, histology, and expression of oxidative stress, inflammation, and apoptosis markers. Further, we evaluated its association with the extracellular signal-regulated kinase (ERK) 1/2 signaling pathway. Results: Mice subjected to I/R injury exhibited typical AKI patterns; serum creatinine level, tubular necrosis, apoptosis, inflammatory cytokine production, and oxidative stress were markedly increased compared to sham mice. However, treatment with iExo attenuated these changes, significantly improving renal function and tissue damage, similar to the renoprotective effects of iMSCs on I/R injury. Significant induction of activated ERK 1/2 signaling molecules was observed in mice treated with iExo compared to those in the I/R injury group. Conclusions: The present study demonstrates that iExo administration ameliorated renal damage following I/R, suggesting that iMSC-derived exosomes may provide a novel therapeutic approach for AKI treatment.
참고문헌 (48)
- Basile DP, "Pathophysiology of acute kidney injury", Compr Physiol, 2, pp.1303~1353 (2012)
- Vinas JL, "Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury", Kidney Int, 90, pp.1238~1250 (2016)
- 한상준, "Mechanisms and therapeutic targets of ischemic acute kidney injury", Kidney Research and Clinical Practice, 38(4), pp.427~440 (2019), 대한신장학회[DOI]
- Mitchell H. Rosner, "Acute kidney injury in the patient with cancer", Kidney Research and Clinical Practice, 38(3), pp.295~308 (2019), 대한신장학회[DOI]
- Cecka M, "Clinical outcome of renal transplantation. Factors influencing patient and graft survival", Surg Clin North Am, 78, pp.133~148 (1998)
- Godwin JG, "Identification of a microRNA signature of renal ischemia reperfusion injury", Proc Natl Acad Sci U S A, 107, pp.14339~14344 (2010)
- Tilney NL, "Effects of initial ischemia", reperfusion injury on the transplanted kidney, 1997, pp.64, 945~947
- Hirschi KK, "Induced pluripotent stem cells for regenerative medicine", Annu Rev Biomed Eng, 16, pp.277~294 (2014)
- Diederichs S, "Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor", Stem Cells Dev, 23, pp.1594~1610 (2014)
- Lian Q, "Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice", Circulation, 121, pp.1113~1123 (2010)
- Rubio D, "Molecular characterization of spontaneous mesenchymal stem cell transformation", PLoS One, 3, pp.e1398~ (2008)
- Jeong JO, "Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy", Circ Res, 108, pp.1340~1347 (2011)
- Ratajczak MZ, "The role of sphingosine-1 phosphate and ceramide-1phosphate in trafficking of normal stem cells and cancer cells", Expert Opin Ther Targets, 18, pp.95~107 (2014)
- Thery C, "Exosomes : composition, biogenesis and function", Nat Rev Immunol, 2, pp.569~579 (2002)
- 권순효, "Extracellular vesicles in renal physiology and clinical applications for renal disease", The Korean Journal of Internal Medicine, 34(3), pp.470~479 (2019), 대한내과학회[DOI]
- Record M, "Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies", Biochim Biophys Acta, 1841, pp.108~120 (2014)
- Arslan F, "Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K", Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia, Stem Cell Res, pp.2013, 10[DOI]
- Bian S, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model", J Mol Med(Berl), 92, pp.387~397 (2014)
- Xin H, "Multipotent mesenchymal stromal cells decrease transforming growth factor β1 expression in microglia", macrophages and down-regulate plasminogen activator inhibitor 1 expression in astrocytes after stroke, 2013, pp.542, 81~86
- Lai RC, "Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation", Regen Med, 8, pp.197~209 (2013)
- Kosaka N, "Functional analysis of exosomal microRNA in cell-cell communication research", Methods Mol Biol, 1024, pp.1~10 (2013)
- Shin YJ, "Therapeutic challenge of minicircle vector encoding klotho in animal model", Am J Nephrol, 49, pp.413~424 (2019)
- Lien YH, "S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure", Kidney Int, 69, pp.1601~1608 (2006)
- Lim SW, "Ginseng increases Klotho expression by FoxO3-mediated manganese superoxide dismutase in a mouse model of tacrolimus-induced renal injury", Aging(Albany NY), 11, pp.5548~5569 (2019)
- Jang HS, "Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia", reperfusion injury, 2013, pp.1832, 1998~2008
- Kumar S, "Dexamethasone ameliorates renal ischemia-reperfusion injury", J Am Soc Nephrol, 20, pp.2412~2425 (2009)
- Zhu G, "Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia", reperfusion injury via transferring miR-199a-3p, 2019, pp.234, 23736~23749
- Collino F, "Exosome and microvesicle-enriched fractions isolated from mesenchymal stem cells by gradient separation showed different molecular signatures and functions on renal tubular epithelial cells", Stem Cell Rev Rep, 13, pp.226~243 (2017)
- Shabbir A, "Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro", Stem Cells Dev, 24, pp.1635~1647 (2015)
- Liang X, "Paracrine mechanisms of mesenchymal stem cell-based therapy : current status and perspectives", Cell Transplant, 23, pp.1045~1059 (2014)
- Baglio SR, "Mesenchymal stem cell secreted vesicles provide novel opportunities in(stem)cell-free therapy", Front Physiol, 3, pp.359~ (2012)
- Orozco L, "Treatment of knee osteoarthritis with autologous mesenchymal stem cells : a pilot study", Transplantation, 95, pp.1535~1541 (2013)
- Wakitani S, "Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect", Microsc Res Tech, 58, pp.14~18 (2002)
- Chiang ER, "Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits", PLoS One, 11, pp.e0149835~ (2016)
- ter Huurne M, "Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis", Arthritis Rheum, 64, pp.3604~3613 (2012)
- Koh YG, "Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis", Knee Surg Sports Traumatol Arthrosc, 23, pp.1308~1316 (2015)
- Sabapathy V, "hiPSC-derived iMSCs : NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine", J Cell Mol Med, 20, pp.1571~1588 (2016)
- Wiklander OP, "Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting", J Extracell Vesicles, 4, pp.26316~ (2015)
- Choi H, "Illuminating the physiology of extracellular vesicles", Stem Cell Res Ther, 7, pp.55~ (2016)
- Grange C, "Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging", Int J Mol Med, 33, pp.1055~1063 (2014)
- Wang R, "Bone marrow mesenchymal stem cell-derived exosome protects kidney against ischemia reperfusion injury in rats", Zhonghua Yi Xue Za Zhi, 94, pp.3298~3303 (2014)
- Imai T, "Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice", J Extracell Vesicles, 4, pp.26238~ (2015)
- Takahashi Y, "Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection", J Biotechnol, 165, pp.77~84 (2013)
- Liu X, "Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration", Nanoscale, 9, pp.4430~4438 (2017)
- Pape AC, "An injectable and drug-loaded supramolecular hydrogel for local catheter injection into the pig heart", J Vis Exp, 100, pp.e52450~ (2015)
- Xu L, "Microwave extraction optimization using the response surface methodology of Fructus Meliae Toosendan polysaccharides and its antioxidant activity", Int J Biol Macromol, 118(Pt B), pp.1501~1510 (2018)
- Zhang K, "Enhanced therapeutic effects of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment", ACS Appl Mater Interfaces, 10, pp.30081~30091 (2018)
- van Balkom BW, "Exosomes and the kidney : prospects for diagnosis and therapy of renal diseases", Kidney Int, 80, pp.1138~1145 (2011)